Axovant Sciences Ltd. (NYSE: AXON) announced the pricing of its underwritten public offering of 6,742,179 of its common shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE